Effect of rituximab dose on induction therapy in ABO-incompatible living kidney transplantation

Abstract

In ABO-incompatible kidney transplantation, low-dose rituximab is more efficacious than higher doses and reduces serious infection risks. Additional randomized controlled trials might be needed to confirm these findings due to small sample size.